UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The NHS England 100,000 Genomes Project: feasibility and utility of centralised genome sequencing for children with cancer

Trotman, Jamie; Armstrong, Ruth; Firth, Helen; Trayers, Claire; Watkins, James; Allinson, Kieren; Jacques, Thomas S; ... Tarpey, Patrick; + view all (2022) The NHS England 100,000 Genomes Project: feasibility and utility of centralised genome sequencing for children with cancer. British Journal of Cancer , 127 pp. 137-144. 10.1038/s41416-022-01788-5. Green open access

[thumbnail of Trotman_et_al-2022-British_Journal_of_Cancer.pdf]
Preview
Text
Trotman_et_al-2022-British_Journal_of_Cancer.pdf - Published Version

Download (1MB) | Preview

Abstract

BACKGROUND: Whole-genome sequencing (WGS) of cancers is becoming an accepted component of oncological care, and NHS England is currently rolling out WGS for all children with cancer. This approach was piloted during the 100,000 genomes (100 K) project. Here we share the experience of the East of England Genomic Medicine Centre (East-GMC), reporting the feasibility and clinical utility of centralised WGS for individual children locally. METHODS: Non-consecutive children with solid tumours were recruited into the pilot 100 K project at our Genomic Medicine Centre. Variant catalogues were returned for local scrutiny and appraisal at dedicated genomic tumour advisory boards with an emphasis on a detailed exploration of potential clinical value. RESULTS: Thirty-six children, representing one-sixth of the national 100 K cohort, were recruited through our Genomic Medicine Centre. The diagnoses encompassed 23 different solid tumour types and WGS provided clinical utility, beyond standard-of-care assays, by refining (2/36) or changing (4/36) diagnoses, providing prognostic information (8/36), defining pathogenic germline mutations (1/36) or revealing novel therapeutic opportunities (8/36). CONCLUSION: Our findings demonstrate the feasibility and clinical value of centralised WGS for children with cancer. WGS offered additional clinical value, especially in diagnostic terms. However, our experience highlights the need for local expertise in scrutinising and clinically interpreting centrally derived variant calls for individual children.

Type: Article
Title: The NHS England 100,000 Genomes Project: feasibility and utility of centralised genome sequencing for children with cancer
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41416-022-01788-5
Publisher version: https://doi.org/10.1038/s41416-022-01788-5
Language: English
Additional information: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Biology and Cancer Dept
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
URI: https://discovery.ucl.ac.uk/id/eprint/10147680
Downloads since deposit
79Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item